A detailed history of Headlands Technologies LLC transactions in Ocugen, Inc. stock. As of the latest transaction made, Headlands Technologies LLC holds 66,172 shares of OCGN stock, worth $78,744. This represents 0.01% of its overall portfolio holdings.

Number of Shares
66,172
Holding current value
$78,744
% of portfolio
0.01%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 12, 2025

BUY
$0.92 - $1.66 $60,878 - $109,845
66,172 New
66,172 $107,000
Q1 2024

May 07, 2024

BUY
$0.5 - $1.83 $20,099 - $73,562
40,198 New
40,198 $65,000

Others Institutions Holding OCGN

About Ocugen, Inc.


  • Ticker OCGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 216,566,000
  • Market Cap $258M
  • Description
  • Ocugen, Inc., a clinical-stage biopharmaceutical company, focuses on the developing gene therapies to cure blindness diseases. The company's pipeline product includes OCU400, a novel gene therapy product candidate restoring retinal integrity and function across a range of genetically diverse inherited retinal diseases, such as retinitis pigmento...
More about OCGN
Track This Portfolio

Track Headlands Technologies LLC Portfolio

Follow Headlands Technologies LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Headlands Technologies LLC, based on Form 13F filings with the SEC.

News

Stay updated on Headlands Technologies LLC with notifications on news.